58 reports of this reaction
1.5% of all AMPHETAMINE SULFATE reports
#10 most reported adverse reaction
OVERDOSE is the #10 most commonly reported adverse reaction for AMPHETAMINE SULFATE, manufactured by Azurity Pharmaceuticals, Inc.. There are 58 FDA adverse event reports linking AMPHETAMINE SULFATE to OVERDOSE. This represents approximately 1.5% of all 3,842 adverse event reports for this drug.
Patients taking AMPHETAMINE SULFATE who experience overdose should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OVERDOSE is a less commonly reported adverse event for AMPHETAMINE SULFATE, but still significant enough to appear in the safety profile.
In addition to overdose, the following adverse reactions have been reported for AMPHETAMINE SULFATE:
The following drugs have also been linked to overdose in FDA adverse event reports:
OVERDOSE has been reported as an adverse event in 58 FDA reports for AMPHETAMINE SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
OVERDOSE accounts for approximately 1.5% of all adverse event reports for AMPHETAMINE SULFATE, making it a notable side effect.
If you experience overdose while taking AMPHETAMINE SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.